BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5458708)

  • 1. [Secondary effects of Moditen-Retard].
    Fouks L
    Encephale; 1970; ():Suppl:14-8. PubMed ID: 5458708
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects of depot fluphenazines.
    Ayd FJ
    Adv Biochem Psychopharmacol; 1974; 9(0):301-9. PubMed ID: 4599435
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluphenazine oenanthate ("Moditen-Retard" N.D.) chemistry and pharmacology].
    Viala A
    Encephale; 1970; ():Suppl:3-9. PubMed ID: 5458710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V; Nica-Udangiu St
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidents and accidents during therapy with long-acting neuroleptics].
    Escande M; Vasquez Villareal S; Gayral L
    Ann Med Psychol (Paris); 1974 Jan; 1(1):112-20. PubMed ID: 4210849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of long-acting fluphenazine].
    Lievre JA; Guillien P; Boccara M
    Presse Med (1893); 1971 Sep; 79(40):1757. PubMed ID: 5120822
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F; Verité P; André D; Colonna L; Boucly P
    Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of fluphenazine oenanthate in psychiatric therapy (personal experience)].
    Darcourt G; Lavagna J; Myquel M; Bècle J
    Ann Med Psychol (Paris); 1971 Oct; 2(3):448-59. PubMed ID: 5128638
    [No Abstract]   [Full Text] [Related]  

  • 10. [Depr;essive syndrome in the course of treatment with Mirenil prolongatum].
    Pawelkiewicz K; Sekrecki T
    Pol Tyg Lek; 1977 Oct; 32(44):1725-6. PubMed ID: 917920
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-acting neuroleptics.
    Lambert PA; Midenet J
    Therapie; 1973; 28(3):521-86. PubMed ID: 4771902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advantages and indications of Moditen-Retard].
    Vallade L
    Encephale; 1970; ():Suppl:10-3. PubMed ID: 5458707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Importance of delayed-action compounds for management of neuroleptic treatments. (Apropos of fluphenazine enanthate)].
    Delay J; Deniker P; Perier M; Dalle B
    Presse Med (1893); 1967 May; 75(24):1243-6. PubMed ID: 6024177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
    Rektor L; Blazek J
    Cesk Psychiatr; 1980; 76(6):369-75. PubMed ID: 7471277
    [No Abstract]   [Full Text] [Related]  

  • 15. [New perspectives offered by an injectable delayed-action neuroleptic: fluphenazine enanthate].
    Lambert PA; Midenet M; Midenet J; Marcou G; Bouchardy M
    Ann Med Psychol (Paris); 1966 May; 124(5):702-7. PubMed ID: 5941462
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant syndromes and sudden death, during treatments with simple and delayed-action neuroleptic drugs].
    Bourgeois M; Tignol J; Henry P
    Ann Med Psychol (Paris); 1971 Dec; 2(5):729-46. PubMed ID: 5144687
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fatal malignant syndromes following direct injection of fluphenazine onanthate].
    Henry P; Barat M; Bourgeois M; Tignol P
    Presse Med (1893); 1971 Jun; 79(29):1350. PubMed ID: 5564013
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complications of the treatment with long-acting neuroleptic preparations. Brain disease due to fluphenazine decanoate].
    Agostini L; Biagini S; Quartesan R
    Acta Neurol (Napoli); 1976; 31(1):74-8. PubMed ID: 970267
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of delayed-action neuroleptics].
    Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
    Ann Med Psychol (Paris); 1969 May; 1(5):772-8. PubMed ID: 5398062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of delayed-action neuroleptics].
    Fouks ; Houssait ; Mathis ; Gay M; Ferragu ; Gilbert
    Ann Med Psychol (Paris); 1969 May; 127(5):772-8. PubMed ID: 5397523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.